DRUG · Mapped RxNorm record
Liraglutide
Normalized identity: liraglutideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
NCT02014740
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Metformin
Normalized identity: metforminView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Overweightunresolved
Obesityverified · MONDO: obesity disorder
Interventions
LiraglutideDRUG · verified · RxNorm: liraglutide
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
University of Miamilead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02014740 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.